Eighty-five strains of Serratia were speciated. The majority were Serratia marcescens and were recovered from a variety of clinical specimens. S. liquefaciens and S. rubidaea were recovered only from sputum.
A proposal has been made (1) that Enterobacter liquefaciens and Bacterium rubidaea be transferred to the genus Serratia, and that three species should be recognized in this genus: S. marcescens, S. liquefaciens, and S. rubidaea.
Ewing et al. (1) reported on 22 extra-intestinal human isolates of S. liquefaciens. Eightytwo percent of these came from respiratory sources, 9% from blood, and 7% from urine. Ewing also reported on 17 extra-intestinal isolates of S. rubidaea. Fifty-nine percent of these came from respiratory sources, 24% from blood, and 18% from wounds and similar sources. S. rubidaea was not recovered from urine specimens.
We considered that it would be of interest to determine what differences may exist in the distribution of these species among various clinical specimens within a single institution.
All aerobic gram-negative rods from primary plating media (Eosin-methylene blue agar) were routinely tested for a variety of biochemical reactions. Serratia species were initially detected by a positive deoxyribonuclease reaction on plates containing this substrate. Deoxyribonuclease-positive isolates were further tested for H2S production (to distinguish Arizona species [2] , phenylalanine deaminase (to rule out the occasional deoxyribonucleasepositive Proteus species), and oxidase (to eliminate Aeromonas species).
Speciation of Serratia was accomplished by noting lysine and ornithine decarboxylation and the fermentation of arabinose (Table 1) . With the exception of a single isolate of S. rubidaea, all strains were nonpigmented after 24 h on Mueller-Hinton agar.
Eighty-five strains of Serratia were recovered over a 6-month period. Seventy-four (87%) were S. marcescens, eight (9%) were S. liquefaciens, and three (3.5%) were S. rubidaea. The average age of the patients was 61 years, and 61% of them were males. The majority of the isolates were recovered from in-patients.
Forty-five percent of the S. marcescens strains were recovered from respiratory specimens (sputum and tracheal aspirates), 43% from urine specimens (voided and catheterized), and 10% from wounds. Two additional isolates were recovered from specimens of urethral exudate and skin.
Strains of S. liquefaciens and S. rubidaea were recovered only from sputum.
All Serratia isolates were resistant to cephalothin as determined by the Kirby-Bauer technique. All isolates of S. liquefaciens and S. rubidaea were susceptible to chloramphenicol and kanamycin. Two of the S. rubidaea isolates were also resistant to tetracycline; the third strain was resistant to ampicillin. Three of the S. liquefaciens strains were susceptible to all antibiotics other than cephalothin; of the remaining five strains, all were resistant to ampicillin, three of these were additionally resistant to tetracycline, three were resistant to polymyxins, and a single isolate was resistant to carbenicillin.
The S. marcescens varied markedly in their susceptibility to ampicillin, tetracycline, and polymyxins. Sixteen percent were resistant to chloramphenicol, 10% to kanamycin, and 22% to chloramphenicol and kanamycin. It is of interest that 77% of the S. marcescens isolates resistant to chloramphenicol and/or kanamycin were urinary isolates. 
